AKCEA THERAPEUTICS (AKCA) earnings
Quarterly and annual AKCA reports and results, each read against the price at its own news timestamp. Back to the AKCA overview →
No AKCA earnings events in the measured window.
Nothing matched in the current window — the AKCA overview has every event we measure for this name.
Get an email when AKCA moves on news →Keep exploring
More AKCA: analyst actions → · SEC filings → · AKCA overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Vericel Corporation (VCEL) | 406 | -0.19% | 40% |
| SPRING BANK PHARMACEUTICALS (SBPH) | 404 | 0.00% | 37% |
| Blueprint Medicines Corporation (BPMC) | 401 | -0.03% | 46% |
| EDGE THERAPEUTICS (EDGE) | 401 | -0.05% | 41% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.